Vitality Watch

Dossier pubmed review 13-nov-2026
Narrative review or expert overview without new data

Metabolic syndrome and Alzheimer’s disease: Mechanistic links and precision prevention (Review).

Key claim: Alzheimer’s disease represents a central neural manifestation of systemic metabolic disorders driven by convergent pathways including insulin resistance, neuroinflammation, vascular dysfunction, and gut-brain axis dysregulation.

Abstract

Metabolic syndrome (MetS) is associated with increased risk of Alzheimer’s disease (AD), however, the majority of previous studies regard MetS as an isolated risk factor and focus on single pathways, lacking systematic understanding of combined effects among multiple metabolic components. The present review systematically summarizes the multifaceted mechanisms by which MetS promotes AD pathology, including insulin resistance and cerebral energy dysregulation, oxidative stress and mitochondrial dysfunction, neuroinflammation and glial cell activation, vascular dysfunction and dysregulation of the renin‑angiotensin system, as well as the central convergent signaling pathway involving glycogen synthase kinase‑3β. The present review further highlights emerging regulatory mechanisms involving the gut‑brain axis, epigenetic reprogramming, sex differences and hormonal effects and senescent microenvironment. By emphasizing the peripheral‑central crosstalk and interactive amplification of MetS components, the present review aimed to position AD as a central manifestation of systemic metabolic disorders in the brain and propose a multi‑domain precision strategy integrating lifestyle intervention, metabolic drug repurposing, gut microbiota regulation, anti‑aging therapy and biomarker‑guided subtype classification for intervention against MetS‑associated AD.

Why this matters

Alzheimer’s disease represents a central neural manifestation of systemic metabolic disorders driven by convergent pathways including insulin resistance, neuroinflammation, vascular dysfunction, and gut-brain axis dysregulation.

Source

Link

Briefing card

Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review).
Stage: review · pubmed · 13-nov-2026

Alzheimer's disease represents a central neural manifestation of systemic metabolic disorders driven by convergent pathways including insulin resistance, neuroinflammation, vascular dysfunction, and gut-brain axis dysregulation.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.3892/ijmm.2026.6051

build build 880 · 2bcef25 · 2026-11-18